1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Assisted Reproductive Technology (ART) Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Assisted Reproductive Technology (ART) Devices Market, North America
3.1 Assisted Reproductive Technology (ART) Devices Market, North America, Revenue ($m), 2018-2033
3.2 Assisted Reproductive Technology (ART) Devices Market, North America, Revenue ($m), 2018-2033
3.3 Assisted Reproductive Technology (ART) Devices Market, North America, Volume (Units), 2018-2033
3.4 Assisted Reproductive Technology (ART) Devices Market, North America, Volume (Units), 2018-2033
3.5 Assisted Reproductive Technology (ART) Devices Market, North America, Company Share by Revenue ($m), 2025
4 Assisted Reproductive Technology (ART) Devices Market, Canada
4.1 Assisted Reproductive Technology (ART) Devices Market, Canada, Revenue ($m), 2018-2033
4.1.1 ART Media Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 ART Micropipettes Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Assisted Reproductive Technology (ART) Devices Market, Canada, Volume (Units), 2018-2033
4.2.1 ART Media Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 ART Micropipettes Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Assisted Reproductive Technology (ART) Devices Market, Canada, Average Price ($), 2018-2033
4.4 Assisted Reproductive Technology (ART) Devices Market, Canada, Company Share by Revenue ($m), 2025
5 Assisted Reproductive Technology (ART) Devices Market, Mexico
5.1 Assisted Reproductive Technology (ART) Devices Market, Mexico, Revenue ($m), 2018-2033
5.1.1 ART Media Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.2 ART Micropipettes Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Assisted Reproductive Technology (ART) Devices Market, Mexico, Volume (Units), 2018-2033
5.2.1 ART Media Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.2 ART Micropipettes Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Assisted Reproductive Technology (ART) Devices Market, Mexico, Average Price ($), 2018-2033
5.4 Assisted Reproductive Technology (ART) Devices Market, Mexico, Company Share by Revenue ($m), 2025
6 Assisted Reproductive Technology (ART) Devices Market, United States
6.1 Assisted Reproductive Technology (ART) Devices Market, United States, Revenue ($m), 2018-2033
6.1.1 ART Media Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.2 ART Micropipettes Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Assisted Reproductive Technology (ART) Devices Market, United States, Volume (Units), 2018-2033
6.2.1 ART Media Market, United States, Volume (Units), by Segment, 2018-2033
6.2.2 ART Micropipettes Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Assisted Reproductive Technology (ART) Devices Market, United States, Average Price ($), 2018-2033
6.4 Assisted Reproductive Technology (ART) Devices Market, United States, Company Share by Revenue ($m), 2025
7 Overview of Key Companies in North America Assisted Reproductive Technology (ART) Devices Market
7.1 CooperSurgical Inc
7.1.1 Company Overview
7.2 Wilson-Cook Medical Inc
7.2.1 Company Overview
7.3 Vitrolife AB
7.3.1 Company Overview
7.4 Fujifilm Biosciences Inc
7.4.1 Company Overview
8 Assisted Reproductive Technology (ART) Devices Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Oct 29, 2025: ASRM Receives $1 Million Donation from Dr. Kwang-Yul Cha for Reproductive Research Grants
9.1.2 Sep 15, 2025: Conceivable Life Sciences Raises $50 Million Series A
9.1.3 Sep 15, 2025: Conceivable Raises $50 Million for Robotic IVF Embryo Lab Development
9.2 Government and Public Interest
9.2.1 Oct 24, 2025: US Fertility Research Team Highlights Innovation and Collaboration at the 2025 ASRM Scientific Congress
9.3 Other Significant Developments
9.3.1 Oct 29, 2025: ASRM Receives $1 Million Donation from Dr. Kwang-Yul Cha for Reproductive Research Grants
9.3.2 Oct 27, 2025: Granata Bio Corporation And Georgetown Equity Partners Form Joint Venture To Develop Next-Generation FSH
9.3.3 Oct 07, 2025: Valley Health Opens New Fertility Practice
9.3.4 Sep 26, 2025: SDFC Launches Summer Promotion for Discounted IVF
9.3.5 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
9.4 Product News
9.4.1 Nov 20, 2025: Overture Life Secures CE Mark Approval for Fertility Automation in Europe
9.4.2 Nov 03, 2025: Femasys Receives FDA Approval to Progress Final FemBloc Trial Phase and Secures $12 Million Financing
9.4.3 Oct 22, 2025: Femasys Initiates Post-Market Surveillance Study for FemBloc Permanent Birth Control in Europe
9.4.4 Oct 22, 2025: Juniper Genomics Recognized in Fast Company's Next Big Things in Tech 2025 List
9.4.5 Oct 20, 2025: CaseBioscience Launches CaseBio Culture and Handling Media After FDA Clearance
9.4.6 Oct 13, 2025: CBIH Launches Women-Centric Fertility Innovation Using Nanoemulsion Delivery
9.4.7 Sep 30, 2025: Sona Launches Brand Partnerships Program, Offering Expecting Parents Over $300 in Perks
9.4.8 Sep 29, 2025: Oct Imaging Measures Cilia Beat Frequency in Human Fallopian Tubes
9.4.9 Sep 15, 2025: Conceivable Life Sciences Raises $50 Million Series A
9.4.10 Sep 15, 2025: Conceivable Raises $50 Million for Robotic IVF Embryo Lab Development
9.4.11 Sep 11, 2025: Scientists Develop Steerable Microbots from Sperm Cells
9.4.12 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
9.4.13 Jun 18, 2025: Acupuncture Significantly Reduces Stress, Pain, and Anxiety for Patients Undergoing IVF
9.5 Strategy And Business Planning
9.5.1 Nov 18, 2025: IVI RMA North America Partners with Mid-Iowa Fertility
9.5.2 Oct 22, 2025: Femasys Initiates Post-Market Surveillance Study for FemBloc Permanent Birth Control in Europe
9.5.3 Oct 07, 2025: Valley Health Opens New Fertility Practice
9.5.4 Oct 06, 2025: LEVY Health Partners With IVF Academy USA to Enhance OB-GYN Training in Fertility Medicine
9.5.5 Sep 15, 2025: Conceivable Life Sciences Raises $50 Million Series A
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer